FDANonrulemakingFDA-2012-D-0847

Who commented on this docket

Draft Guidance for IRBs, Clinical Investigators, and Sponsors: IRB Responsibilities for Reviewing the Qualifications of Investigators, Adequacy of Research Sites, and the Determination of Whether an IND/IDE is Needed

1 organizations filed 1 public comment on Draft Guidance for IRBs, Clinical Investigators, and Sponsors: IRB Responsibilities for Reviewing the Qualifications of Investigators, Adequacy of Research Sites, and the Determination of Whether an IND/IDE is Needed, at the Food and Drug Administration. The comment window closed 4935d ago.

Organizations
1
Comments
1
RIN
Comment window
closed 4935d ago

Commenters (1)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.